Thrombosis is the main cause of failure of small-diameter synthetic vascular grafts when
used for by-pass procedures. The development of bioresorbable vascular scaffolds with …

Herein biodegradable poly (ε-caprolactone) was electrospun into tubular microfibrous
scaffolds and modified by the surface heparinization and wrapping of Type I collagen suture …

The main challenge encountered in clinical efficacy of tissue engineered vascular grafts is
development of a biomimetic scaffold. To establish a scaffold resembling the architecture of …

The less-than-ideal cell infiltration resulting from inherently small pore size limits the
application of electrospinning scaffold in tissue engineering and regeneration medicine. The …

Acellular biodegradable small diameter vascular grafts (SDVGs) require antithrombosis,
intimal hyperplasia inhibition and rapid endothelialization to improve the graft patency …

Small-diameter synthetic vascular grafts are required for surgical bypass grafting when there
is a lack of suitable autologous vessels due to different reasons, such as previous …

Aiming to construct small diameter (ID< 6 mm) off‐the‐shelf tissue‐engineered vascular
grafts, the end‐group heparinizd poly (ε‐caprolactone)(PCL) is synthesized by a three‐step …

The replacement of small-diameter vessels is one of the main challenges in tissue
engineering. Moreover, the surface modification of small-diameter vascular grafts (SDVG) is …

Tissue engineering can effectively contribute to the development of novel vascular
prostheses aimed to overcome the well‐known drawbacks of small‐diameter grafts. To date …

In this study, we tested in vivo effectiveness of a previously developed poly-L-lactide/poly-8-
caprolactone armored vascular graft releasing heparin. This bioprosthesis was designed in …